AURA AURA BIOSCIENCES INC

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 10:50 a.m. ET.

The live webcast of the fireside chat will be available on the “Investors & Media” page under the “Events & Presentations” section of the Company’s website at , where a replay of the webcast will be archived for 90 days following the presentation date.

About Aura Biosciences

Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for early choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura Biosciences is headquartered in Boston, MA. Our mission is to grow as an innovative global oncology company that positively transforms the lives of patients.

For more information, visit . Follow us on X (formerly Twitter) @AuraBiosciences and visit us on LinkedIn.

Investor and Media Relations Contact:

Alex Dasalla

Head of Investor Relations and Corporate Communications



EN
24/11/2025

Underlying

AURAAURA BIOSCIENCES INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AURA BIOSCIENCES INC

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.35
TGTX TG Therapeutics...
TFX Teleflex Incorp... ... (+24)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

TGTX TG THERAPEUTICS INC.
TFX TELEFLEX INCORPORATED
SRPT SAREPTA THERAPEUTICS INC.
OOMA OOMA
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
FFIV F5 NETWORKS INC.
EXTR EXTREME NETWORKS INC.
EPC EDGEWELL PERSONAL CARE CO.
ACHC ACADIA HEALTHCARE COMPANY INC.
JW.A JOHN WILEY & SONS INC. CLASS A
SAH SONIC AUTOMOTIVE INC. CLASS A
AWK AMERICAN WATER WORKS COMPANY INC.
CRI CARTER'S INC.
UAA UNDER ARMOUR INC. CLASS A
BCBP BCB BANCORP INC.
WH WYNDHAM HOTELS & RESORTS INC.
STRA STRATEGIC EDUCATION INC.
BJ BJ'S WHOLESALE CLUB HOLDINGS
HPK HIGHPEAK ENERGY INC (A)
AURA AURA BIOSCIENCES INC
CURV TORRID HOLDINGS INC
CAVA CAVA GROUP INC
IBTA IBOTTA INC
AOUT AMERICAN OUTDOOR BRANDS INC
04/01/26 April 1, 2026 1 EN
 PRESS RELEASE
Free
AURA AURA BIOSCIENCE...

Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial R...

Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Accelerated Phase 3 CoMpass Enrollment Supports Mid-2026 Enrollment Completion and 2H 2027 Topline Data Guidance Phase 1b/2 NMIBC Trial on Track: Initial 3-Month Clinical Data Expected Mid-2026 12-month Stability Completed with New Formulation with Potential Across Non-ocular Solid Tumor Indications, Beginning with Urologic Oncology BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed...

March 30, 2026 1 EN
Hybridan Team
  • Hybridan Team
JLP Jubilee Metals ...
SWG Shearwater Grou... ... (+10)

Hybridan Small Cap Feast: 12 March 2026

12th March 2026 @HybridanLLP Our daily digest of news from UK Small Caps * A corporate client of Hybridan LLP. ** Potential means Intention to Float (ITF) or similar announcement has been made. ***Arranged by type of listing and date of announcement. ****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication. Dish of the Day Admissions: None Delistings: None Wh...

JLP JUBILEE METALS GROUP
SWG SHEARWATER GROUP
AEE AURA ENERGY
0FK ASIAMET RESOURCES LTD
ABDX ABINGDON HEALTH
AURA AURA BIOSCIENCES INC
COBR COBRA RESOURCES PLC
FCM FIRST CLASS METALS PLC
OPT OPTIMA HEALTH PLC
GEX GEORGINA ENERGY PLC
03/12/26 March 12, 2026 1 EN
 PRESS RELEASE
Free
AURA AURA BIOSCIENCE...

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences to Participate in Upcoming Investor Conferences BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) --  (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that members of its senior management team will participate in the following upcoming investor conferences: TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026. Fireside Chat at 9:10 a.m. ET. Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026. Fireside Chat at 3:40 p.m. ET. The Citizen...

February 25, 2026 1 EN
 PRESS RELEASE
Free
AURA AURA BIOSCIENCE...

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare ...

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 10:50 a.m. ET. The live webcast of the fireside chat will be available on the “Investors & Media” page under the “Events & Presentations” ...

November 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch